Cargando…

Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial

Postprandial glucose control remains challenging for patients with type 1 diabetes (T1D). A simplified meal bolus approach with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS) has been tested; yet, the impact of categorization errors with this strategy is unknown. The objective was...

Descripción completa

Detalles Bibliográficos
Autores principales: Gingras, Véronique, Smaoui, Mohamed Raef, Cameli, Charlotte, Messier, Virginie, Ladouceur, Martin, Legault, Laurent, Rabasa-Lhoret, Rémi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805693/
https://www.ncbi.nlm.nih.gov/pubmed/29422651
http://dx.doi.org/10.1038/s41598-018-20785-4
_version_ 1783299004895854592
author Gingras, Véronique
Smaoui, Mohamed Raef
Cameli, Charlotte
Messier, Virginie
Ladouceur, Martin
Legault, Laurent
Rabasa-Lhoret, Rémi
author_facet Gingras, Véronique
Smaoui, Mohamed Raef
Cameli, Charlotte
Messier, Virginie
Ladouceur, Martin
Legault, Laurent
Rabasa-Lhoret, Rémi
author_sort Gingras, Véronique
collection PubMed
description Postprandial glucose control remains challenging for patients with type 1 diabetes (T1D). A simplified meal bolus approach with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS) has been tested; yet, the impact of categorization errors with this strategy is unknown. The objective was to compare, in a randomized controlled inpatient trial, DH-CLS with the simplified meal bolus approach for two different meals properly categorized or overestimated. We tested, in patients with T1D, the simplified strategy with two standardized breakfasts (n = 10 per meal) adequately categorized or overestimated: (1) 75 g and (2) 45 g of carbohydrate. No difference was observed for percentage of time <4.0 mmol/L over a 4-hour post-meal period (primary outcome; median [IQR]: 0[0–0] vs. 0[0–0] for both comparisons, p = 0.47 and 0.31 for the 75 g and 45 g meals, respectively). Despite higher meal insulin boluses with overestimation for both meals (9.2 [8.2–9.6] vs. 8.1 [7.3–9.1] U and 8.4 [7.2–10.4] vs. 4.8 [3.7–5.6] U; p < 0.05), mean glycemia, percentage of time in target range and glucagon infusion did not differ. Additional scenarios were tested in silico with comparable results. These results suggest that the DH-CLS with a simplified meal bolus calculation is probably able to avoid hypoglycemia in the event of meal size misclassification.
format Online
Article
Text
id pubmed-5805693
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58056932018-02-16 Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial Gingras, Véronique Smaoui, Mohamed Raef Cameli, Charlotte Messier, Virginie Ladouceur, Martin Legault, Laurent Rabasa-Lhoret, Rémi Sci Rep Article Postprandial glucose control remains challenging for patients with type 1 diabetes (T1D). A simplified meal bolus approach with a dual-hormone (insulin and glucagon) closed-loop system (DH-CLS) has been tested; yet, the impact of categorization errors with this strategy is unknown. The objective was to compare, in a randomized controlled inpatient trial, DH-CLS with the simplified meal bolus approach for two different meals properly categorized or overestimated. We tested, in patients with T1D, the simplified strategy with two standardized breakfasts (n = 10 per meal) adequately categorized or overestimated: (1) 75 g and (2) 45 g of carbohydrate. No difference was observed for percentage of time <4.0 mmol/L over a 4-hour post-meal period (primary outcome; median [IQR]: 0[0–0] vs. 0[0–0] for both comparisons, p = 0.47 and 0.31 for the 75 g and 45 g meals, respectively). Despite higher meal insulin boluses with overestimation for both meals (9.2 [8.2–9.6] vs. 8.1 [7.3–9.1] U and 8.4 [7.2–10.4] vs. 4.8 [3.7–5.6] U; p < 0.05), mean glycemia, percentage of time in target range and glucagon infusion did not differ. Additional scenarios were tested in silico with comparable results. These results suggest that the DH-CLS with a simplified meal bolus calculation is probably able to avoid hypoglycemia in the event of meal size misclassification. Nature Publishing Group UK 2018-02-08 /pmc/articles/PMC5805693/ /pubmed/29422651 http://dx.doi.org/10.1038/s41598-018-20785-4 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Gingras, Véronique
Smaoui, Mohamed Raef
Cameli, Charlotte
Messier, Virginie
Ladouceur, Martin
Legault, Laurent
Rabasa-Lhoret, Rémi
Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial
title Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial
title_full Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial
title_fullStr Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial
title_full_unstemmed Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial
title_short Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial
title_sort impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - a randomized controlled trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805693/
https://www.ncbi.nlm.nih.gov/pubmed/29422651
http://dx.doi.org/10.1038/s41598-018-20785-4
work_keys_str_mv AT gingrasveronique impactoferroneousmealinsulinboluswithdualhormoneartificialpancreasusingasimplifiedbolusstrategyarandomizedcontrolledtrial
AT smaouimohamedraef impactoferroneousmealinsulinboluswithdualhormoneartificialpancreasusingasimplifiedbolusstrategyarandomizedcontrolledtrial
AT camelicharlotte impactoferroneousmealinsulinboluswithdualhormoneartificialpancreasusingasimplifiedbolusstrategyarandomizedcontrolledtrial
AT messiervirginie impactoferroneousmealinsulinboluswithdualhormoneartificialpancreasusingasimplifiedbolusstrategyarandomizedcontrolledtrial
AT ladouceurmartin impactoferroneousmealinsulinboluswithdualhormoneartificialpancreasusingasimplifiedbolusstrategyarandomizedcontrolledtrial
AT legaultlaurent impactoferroneousmealinsulinboluswithdualhormoneartificialpancreasusingasimplifiedbolusstrategyarandomizedcontrolledtrial
AT rabasalhoretremi impactoferroneousmealinsulinboluswithdualhormoneartificialpancreasusingasimplifiedbolusstrategyarandomizedcontrolledtrial